ClinConnect ClinConnect Logo
Search / Trial NCT06436716

Artificial Intelligence Model for Traumatic Cervical Spinal Cord Injury Based on Radiomics and Genomics

Launched by AFFILIATED 2 HOSPITAL OF NANTONG UNIVERSITY · May 24, 2024

Trial Information

Current as of May 18, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how artificial intelligence (AI) can help understand and improve care for people who have experienced traumatic injuries to their cervical spinal cord (the part of the spine in the neck). The goal is to collect important information from patients, including MRI images and clinical data, to create a comprehensive database that can be used for research. By gathering this information, the trial aims to enhance cooperation among different hospitals and researchers, ultimately improving treatment options for spinal cord injuries.

To participate in this trial, you may be eligible if you have been diagnosed with a cervical spinal cord injury and have had an MRI taken within 48 hours of your injury. Researchers are looking for patients of all ages and genders. Participants can expect to contribute to a larger effort to improve spinal cord injury data and research, which could lead to better outcomes for future patients. It’s important to note that individuals with certain types of mild injuries or poor-quality MRI scans may not qualify for this study.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. MRI Diagnosis of TCSCI
  • 2. Clinic Diagnosis of TCSCI
  • 3. The injury site must be in cervical spinal cord
  • 4. MRI images of T2WI must be collected within 48 hours after injury
  • 5. Complete and available imaging data, clinical data, including MRI, sex, age
  • Exclusion Criteria:
  • 1. Spinal cord concussion and MRI scans have no obvious positive performance of spinal cord
  • 2. The quality of MRI images is insufficient or there are serious motion artifacts

About Affiliated 2 Hospital Of Nantong University

Affiliated 2 Hospital of Nantong University is a leading medical institution dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital leverages its state-of-the-art facilities and a team of experienced healthcare professionals to conduct high-quality research in various medical fields. Committed to improving patient outcomes, the hospital collaborates with academic institutions and industry partners to facilitate the development of new therapies and treatment protocols, ensuring that cutting-edge medical advancements are accessible to the community it serves.

Locations

Nantong, Jiangsu, China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported